| Patents for A61P 17 - Drugs for dermatological disorders (106,455) |
|---|
| 12/19/2001 | EP1163212A1 Amide derivatives |
| 12/19/2001 | EP1163208A2 Caspase inhibitors and uses thereof |
| 12/19/2001 | EP1163204A1 Lipoxin compounds and their use |
| 12/19/2001 | EP1163003A1 Treatment of lfa-1 associated disorders with increasing doses of lfa-1 antagonist |
| 12/19/2001 | EP1162990A1 Treatment with small peptides to effect antifibrotic activity |
| 12/19/2001 | EP1162989A1 Use of dictyotal extracts in the production of a topical composition |
| 12/19/2001 | EP1162984A2 Use of cross linked polysaccharides for the inhibition of angiogenesis |
| 12/19/2001 | EP1162970A2 Anti-inflammatory uses of manzamines |
| 12/19/2001 | EP1162968A1 Use of epigallocatechin-gallate for inhibiting angiogenesis |
| 12/19/2001 | EP1162937A1 Compositions based on chondroitin sulphate and chitosan for preventing or treating rheumatic disorders by general administration |
| 12/19/2001 | EP0841899B1 Compositions for topical delivery of active ingredients |
| 12/19/2001 | EP0813520B1 Arylsulfonylamino hydroxamic acid derivatives |
| 12/19/2001 | EP0785781B1 Use of indole derivatives for the treatment of dermatological disorders peripheral neuropathied, arthritis, allergic or chronic obstructive airways disease, glaucoma and ocular inflammation |
| 12/19/2001 | EP0766557B1 Topical compositions comprising n-acetyl-l-cysteine |
| 12/19/2001 | EP0717985B1 Dermatologic preparation |
| 12/19/2001 | EP0707849B1 Use of derivatives of 2,4-disubstituted phenols as 5-lipoxigenase inhibitors |
| 12/19/2001 | CN1327382A Improved formulation for topical non-invasive application in vivo |
| 12/19/2001 | CN1326767A Baifujing for curing neurodermatitis |
| 12/19/2001 | CN1326766A Blood cooling and psoriasis cleaning Chinese patent medicine capsule for curing psoriasis |
| 12/19/2001 | CN1326753A Musk skin growing ointment |
| 12/19/2001 | CN1326742A Quick recovery ointment for tinea skin |
| 12/19/2001 | CN1326737A External use medicine for curing sexual disease and its preparing process |
| 12/18/2001 | US6331642 Vitamin D3 analogs |
| 12/18/2001 | US6331640 Diaminopropionic acid derivatives |
| 12/18/2001 | US6331615 Nucleic acid molecule encoding heavy or light chain of an antibody which specifically recognizes a protein specifically recognized by monoclonal antibody 5c8 (anti-CD40 ligand) |
| 12/18/2001 | US6331570 Active enantiomer of RARγ-specific agonist |
| 12/18/2001 | US6331556 Benzofuran-4-carboxylic acid amide derivatives used as phosphodiesterase iv or tumor necrosis factor inhibitors |
| 12/18/2001 | US6331535 Retinyl carbonate derivatives, preparation process and uses |
| 12/18/2001 | US6331433 Human T cell leukemia cell line designated D1.1 |
| 12/18/2001 | US6331423 Nucleotide sequences coding polypeptide for use as human therapeutic agents that modulate kinase activity |
| 12/18/2001 | US6331411 TopA |
| 12/18/2001 | US6331410 Polynucleotides encoding a novel pyrR homolog |
| 12/18/2001 | US6331309 Hydrogel compositions for the controlled release administration of growth factors |
| 12/18/2001 | US6331306 Cosmetics, high water content yet viscosity of a cream, silicone emulsifying agent which is a dimethicone copolyol |
| 12/18/2001 | US6331298 Wound healing and treatment of fibrotic disorders |
| 12/18/2001 | CA2221448C Antisense oligonucleotide modulation of raf gene expression |
| 12/18/2001 | CA2202484C Use of indole derivatives for the treatment of various diseases |
| 12/18/2001 | CA2192665C Methods of lightening hyperpigmented regions in mammalian skin |
| 12/18/2001 | CA2178161C Indole derivatives |
| 12/18/2001 | CA2063610C Method for the treatment of aging or photo-damaged skin |
| 12/13/2001 | WO2001094612A2 Method for identifying medically valuable active substances |
| 12/13/2001 | WO2001094586A2 Non-agonistic antibodies to human gp39, compositions containing, and therapeutic use thereof |
| 12/13/2001 | WO2001094415A2 Nuclear hormone receptor |
| 12/13/2001 | WO2001094413A2 B7-related nucleic acids and polypeptides and their uses for immunomodulation |
| 12/13/2001 | WO2001094391A2 Intracellular signaling proteins |
| 12/13/2001 | WO2001094382A1 Oligopeptides |
| 12/13/2001 | WO2001094381A2 Novel compounds of the n-acylamino-amide family, compositions comprising same, and uses |
| 12/13/2001 | WO2001094368A1 2-aminocarbonyl-9h-purine derivatives |
| 12/13/2001 | WO2001094351A1 Caspase inhibitors and uses thereof |
| 12/13/2001 | WO2001094321A1 Bicyclic cyclohexylamines and their use as nmda receptor antagonists |
| 12/13/2001 | WO2001094319A1 Compounds effective as beta-2-adrenoreceptor agonists as well as pde4-inhibitors |
| 12/13/2001 | WO2001094312A2 Indolinone derivatives as protein kinase/phosphatase inhibitors |
| 12/13/2001 | WO2001094307A1 Propanolaminotetralines, preparation thereof and compositions containing same |
| 12/13/2001 | WO2001094293A2 Benzamide ligands for the thyroid receptor |
| 12/13/2001 | WO2001093889A2 Vip-related peptides for the treatment of skin disorders |
| 12/13/2001 | WO2001093887A1 Skin treatment preparation |
| 12/13/2001 | WO2001093885A1 Therapeutic agents - ii |
| 12/13/2001 | WO2001093884A1 Therapeutic agents - i |
| 12/13/2001 | WO2001093883A1 Therapeutic agents - iii |
| 12/13/2001 | WO2001093882A1 Purified material having size and growth inhibitory effects on cells and tissues |
| 12/13/2001 | WO2001093879A1 Biologically active agents and drugs |
| 12/13/2001 | WO2001093867A1 4,5-dihydro-thiazo-2-ylamine derivatives and their use as no-synthase inhibitors |
| 12/13/2001 | WO2001093858A2 Use of an aluminium and ethylenediamine-tetraacetic complex for preventing and/or treating urticaria |
| 12/13/2001 | WO2001093857A1 Composition for pain mediation and apparatus and method of use thereof |
| 12/13/2001 | WO2001093855A1 Skin-moistening compositions and skin-moistening foods |
| 12/13/2001 | WO2001045668A3 Stable extended release oral dosage composition comprising pseudoephedrine and desloratadine |
| 12/13/2001 | WO2001044445A3 Human lyases and associated proteins |
| 12/13/2001 | WO2001044200A3 Selective neurokinin antagonists |
| 12/13/2001 | WO2001037820A3 Ionizable indolinone derivatives and their use as ptk ligands |
| 12/13/2001 | WO2001027136A3 Peptides which stimulate the immune response and tissue regeneration |
| 12/13/2001 | WO2001018181A3 Enzyme inhibitors |
| 12/13/2001 | WO2000032179A3 Use of nicotonic acid derivatives for the treatment of dna damage in skin cells |
| 12/13/2001 | US20010051650 Topical compositions comprising ascomycins |
| 12/13/2001 | US20010051170 Use of compounds which make it possible to modify the physicochemical properties of the skin and/or the mucous membranes as agents preventing or reducing the adhesion of microorganisms to the latter |
| 12/13/2001 | US20010051169 Halogenated alkylnyl carbamate and a saturated or unsaturated acylic, cyclic polyol or polyol ether for the treatment of inflammatory and/or desquamating skin disorders associated with Malassezia species; antidandruff agent |
| 12/13/2001 | US20010051139 Therapy for skin disorders |
| 12/13/2001 | EP1143954A3 Use of nicotonic acid derivatives for the treatment of dna damage in skin cells |
| 12/13/2001 | DE10101324C1 New 1-(dimercaptoalkyl)-quinazoline-2,4(1H,3H)-diones, are stable matrix metalloproteinase inhibitors useful e.g. for treating rheumatism, tumor metastasis or sunburn |
| 12/13/2001 | DE10028718A1 Kosmetische Stifte Cosmetic sticks |
| 12/13/2001 | DE10026998A1 Verfahren zur Herstellung einer kosmetischen Zusammensetzung, die humanes Serum Albumin umfasst, welches aus transgenen nicht-menschlichen Säugern erhalten wurde A process for the preparation of a cosmetic composition comprising human serum albumin, which has been obtained from transgenic non-human mammals |
| 12/13/2001 | DE10025609A1 Transfektionssystem Transfection |
| 12/13/2001 | CA2412377A1 B7-related nucleic acids and polypeptides and their uses for immunomodulation |
| 12/13/2001 | CA2411596A1 Therapeutic agents - ii |
| 12/13/2001 | CA2411351A1 Compounds effective as beta-2-adrenoreceptor agonists as well as pde4-inhibitors |
| 12/13/2001 | CA2411067A1 Oligopeptides for promoting hair growth |
| 12/13/2001 | CA2411062A1 Benzamide ligands for the thyroid receptor |
| 12/13/2001 | CA2410509A1 Indolinone derivatives as protein kinase/phosphatase inhibitors |
| 12/13/2001 | CA2410188A1 Non-agonistic antibodies to human gp39, compositions containing, and therapeutic use thereof |
| 12/13/2001 | CA2409392A1 Intracellular signaling proteins |
| 12/13/2001 | CA2409015A1 Caspase inhibitors and uses thereof |
| 12/13/2001 | CA2408748A1 Nuclear hormone receptor |
| 12/13/2001 | CA2408670A1 Novel compounds of the n-acylamino-amide family, compositions comprising same, and uses |
| 12/13/2001 | CA2407164A1 Bicyclic cyclohexylamines and their use as nmda receptor antagonists |
| 12/12/2001 | EP1161945A2 Pharmaceutical composition based on proline, glycine and lysine used in the therapy for the healing of tendon lesions and open wounds |
| 12/12/2001 | EP1161937A2 Cosmetic sticks |
| 12/12/2001 | EP1161448A1 49 human secreted proteins |
| 12/12/2001 | EP1161444A1 A novel inhibitor of programmed cell death |
| 12/12/2001 | EP1161442A2 Exocytosis pathway proteins and methods of use |
| 12/12/2001 | EP1161433A1 Tyrosine kinase inhibitors |
| 12/12/2001 | EP1161431A1 6-azaindole compounds as antagonists of gonadotropin releasing hormone |